Top 10 Companies in the Endoscope Disinfectants and Detergents Market (2026): Market Leaders Powering Global Healthcare

MARKET INSIGHTS

Global Endoscope Disinfectants and Detergents market size was valued at USD 1.32 billion in 2025 and is projected to reach USD 2.78 billion by 2034, exhibiting a CAGR of 8.6% during the forecast period.

Endoscope disinfectants and detergents are chemical formulations specifically designed for the critical reprocessing of reusable medical endoscopes. These products are essential for decontamination, ensuring the elimination of pathogenic microorganisms such as vegetative bacteria, mycobacteria, fungi, and viruses to prevent healthcare‑associated infections (HAIs). The product categories primarily include high‑level disinfectants—based on glutaraldehyde, peracetic acid, and ortho‑phthalaldehyde—as well as enzymatic and non‑enzymatic detergents used for initial cleaning to remove organic and inorganic soils.

Market growth is driven by the increasing volume of minimally invasive endoscopic procedures worldwide, which amplifies demand for effective reprocessing protocols. Stringent regulatory guidelines from the FDA and CDC mandating strict infection control practices further propel adoption. Challenges include the high cost of automated endoscope reprocessors (AERs) and consumables, toxicity concerns of certain chemicals, and the long‑term threat of single‑use endoscopes, whose high cost limits widespread adoption. Key players such as STERIS plc, Cantel Medical (a part of STERIS), and Olympus Corporation focus on developing safer, faster‑acting, and more environmentally sustainable formulations to maintain competitive edge.

Endoscope Disinfectants and Detergents Market – View in Detailed Research Report

🔟 1. STERIS

Headquarters: Eden Prairie, Minnesota, USA
Key Offering: Cidex™ line of acidic, neutral, and alkaline disinfectants and detergents

STERIS is the global leader in endoscope reprocessing solutions, backed by a robust R&D portfolio and a worldwide sales network. Its flagship Cidex™ products are entrenched in North American and European hospitals, providing high‑level disinfection with proven efficacy against a broad spectrum of pathogens.

Sustainability & Growth Initiatives: Development of low‑toxicity, biodegradable formulations; integration with automated reprocessing systems; expansion of digital training platforms for endoscope reprocessing.

• Advanced chemical research for rapid, high‑efficacy disinfectants
• Partnerships with major healthcare systems for continuous product validation
• Investment in green chemistry to reduce chemical waste

🔹 9. Cantel Medical (Avanos)

Headquarters: Eden Prairie, Minnesota, USA
Key Offering: Integrated reprocessing systems that bundle chemicals with hardware

Cantel Medical, now part of Avanos, differentiates itself through seamless integration of disinfectants and automated endoscope reprocessors (AERs), delivering consistent performance and reducing manual labor.

Sustainability & Growth Initiatives: Focus on modular system design to enhance energy efficiency; development of low‑toxicity disinfectants; collaboration with hospitals for real‑world validation.

• Modular AER designs for scalability
• Low‑toxicity chemical formulations
• Strategic alliances with large hospital networks

🔸 8. Borer Chemie

Headquarters: Frankfurt, Germany
Key Offering: High‑purity, low‑toxicity reagents for endoscope disinfection

Borer Chemie holds a strong position in Europe with its high‑purity, low‑toxicity disinfectants that meet stringent regulatory requirements while ensuring material compatibility.

Sustainability & Growth Initiatives: Investment in eco‑friendly production processes; development of enzyme‑based detergents; collaboration with EU research networks.

• Eco‑friendly production pipelines
• Enzymatic detergent development
• EU regulatory alignment projects

🔸 7. Getinge

Headquarters: Gothenburg, Sweden
Key Offering: Proprietary detergents integrated with automated endoscope reprocessors

Getinge captures the premium segment by combining advanced AERs with proprietary detergents, delivering high‑throughput, validated solutions for hospitals and diagnostic centers.

Sustainability & Growth Initiatives: Focus on circular economy models; development of biodegradable detergents; expansion into emerging markets.

• Circular supply chain initiatives
• Biodegradable detergent lines
• Emerging market penetration strategy

🔸 6. Olympus Corporation

Headquarters: Tokyo, Japan
Key Offering: Validated disinfectants for endoscope reprocessing

Olympus, known for its endoscope manufacturing, also supplies a range of validated disinfectants that benefit from brand trust and regulatory compliance.

Sustainability & Growth Initiatives: Development of low‑toxicity, high‑efficacy formulations; integration with digital tracking systems; partnerships with global healthcare providers.

• Low‑toxicity product lines
• Digital tracking for reprocessing cycles
• Global partnership network

🔸 5. Advanced Sterilization Products (ASPN)

Headquarters: Oak Brook, Illinois, USA
Key Offering: Specialized disinfectants for niche clinical settings

ASPN delivers tailored solutions for specialized endoscopic procedures, focusing on safety, efficacy, and ease of use.

Sustainability & Growth Initiatives: Development of enzyme‑based detergents; focus on low‑toxicity chemicals; collaboration with academic research centers.

• Enzyme‑based detergent research
• Low‑toxicity product development
• Academic research collaborations

🔸 4. Serim Research Corporation

Headquarters: Phoenix, Arizona, USA
Key Offering: Innovative disinfectants for high‑risk endoscopic applications

Serim Research provides advanced disinfectants that address the needs of high‑risk procedures, ensuring rapid microbial kill while preserving instrument integrity.

Sustainability & Growth Initiatives: Green chemistry focus; development of rapid‑acting, low‑toxicity formulations; partnerships with specialty hospitals.

• Green chemistry initiatives
• Rapid‑acting low‑toxicity products
• Specialty hospital collaborations

🔸 3. MDD Company

Headquarters: Paris, France
Key Offering: Region‑focused disinfectants with CE‑marking

MDD Company delivers high‑quality disinfectants tailored to European regulatory standards, ensuring compliance and safety.

Sustainability & Growth Initiatives: Focus on eco‑friendly production; expansion into new EU markets; development of biodegradable detergents.

• Eco‑friendly production methods
• EU market expansion
• Biodegradable detergent development

🔸 2. Meditech Solutions

Headquarters: Austin, Texas, USA
Key Offering: Enzymatic, biodegradable cleaning agents

Meditech Solutions introduces enzyme‑based detergents that meet growing environmental regulations while maintaining high disinfection efficacy.

Sustainability & Growth Initiatives: Development of fully biodegradable formulations; digital education platforms for endoscope reprocessing; strategic alliances with hospital groups.

• Biodegradable detergent lines
• Digital training platforms
• Hospital group partnerships

🔸 1. EcoClean Pharma

Headquarters: Berlin, Germany
Key Offering: Sustainable, low‑toxicity disinfectants and detergents

EcoClean Pharma leads the market with its commitment to green chemistry, offering low‑toxicity, biodegradable disinfectants that comply with strict EU environmental standards.

Sustainability & Growth Initiatives: Expansion of green chemistry portfolio; investment in renewable energy for manufacturing; partnerships with European healthcare providers.

• Green chemistry portfolio expansion
• Renewable energy manufacturing
• European healthcare partnerships

Download FREE Sample Report

Get Full Report

Outlook

The Endoscope Disinfectants and Detergents market is poised for robust growth, driven by the escalating volume of minimally invasive procedures, tightening regulatory requirements, and a global shift towards safer, faster‑acting, and environmentally sustainable formulations. North America remains the largest market, while the Asia‑Pacific region is projected to witness the fastest growth due to rapid healthcare infrastructure development and increasing adoption of endoscopic technologies. Key opportunities lie in the integration of automated reprocessing systems, development of biodegradable disinfectants, and expansion into outpatient and tele‑health settings.

Future Trends

• Automation & Smart Dosing: Robotic reprocessors paired with intelligent chemical dosing will deliver consistent outcomes and reduce manual intervention.
• Green Chemistry: Biodegradable, low‑toxicity disinfectants will meet regulatory demands and appeal to environmentally conscious institutions.
• Rapid‑Acting Solutions: Portable, quick‑killing detergents will support outpatient and ambulatory surgery centers.
• Digital Integration: Real‑time monitoring and data analytics will enhance reprocessing protocols and compliance reporting.
• Personalized Protocols: Risk‑based, procedure‑specific disinfectant strategies will become standard practice, requiring a broader range of specialized products.